DreaMed Advisor Pro System in Subjects With Type 1 Diabetes Treated With MDI Therapy

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 27, 2019

Primary Completion Date

February 28, 2021

Study Completion Date

April 30, 2021

Conditions
Insulin-dependent Diabetes MellitusDiabetes Mellitus, Type 1
Interventions
DEVICE

Advisor Pro

The DreaMed Advisor Pro software is a proprietary algorithm, designed to provide a comprehensive analysis of individual diabetes data which consists of glucose levels and insulin delivery history. the Advisor Pro algorithm identifies glucose patterns and their possible causes, which may hamper the patient's glucose control, and recommend on adjustment to the patient-specific insulin treatment profiles as well as suggestions for personalized diabetes management tips (such as timing of meal boluses, bolus delivery compliance and personalized glucose targets).

Trial Locations (1)

Unknown

Schneider MC, Petah Tikva

Sponsors

Lead Sponsor

All Listed Sponsors
lead

DreaMed Diabetes

INDUSTRY